Susanne Schüler1, Marvin Ponnath, Jörg Engel, Olaf Ortmann. 1. Department of Obstetrics and Gynecology, University of Regensburg, Caritas-Hospital St. Josef, Landshuter Straße 65, 93053 Regensburg, Germany. sschueler@caritasstjosef.de
Abstract
PURPOSE: The aim of this systematic review is to summarize the current knowledge about the etiology and pathogenesis of borderline tumors ovarian cancer with special emphasis on the role of endocrine treatments and reproductive factors to establish a foundation for future studies. METHODS: We performed a systematic review on the relation between ovarian epithelial tumors (OET) and reproductive factors using the keywords: ovarian cancer, ovarian tumor, ovarian borderline tumor, age at menarche, age at menopause, parity, infertility, PCO syndrome, oral contraception, menopausal hormone therapy, fertility treatment. Totally, 3,290 abstracts were scanned for their relevance in this publication and 127 were finally included. RESULTS: The incidence of ovarian epithelial cancer and ovarian borderline tumors is influenced by certain reproductive factors. The strongest protective effects are conferred by parity and use of oral contraceptive pills. Recent molecular biologic and histopathologic studies prove that OET represent a diverse group of tumors, each histologic type with a different genetic background. This is at least partly reflected in epidemiologic and clinical studies showing different risk modulating effects of reproductive factors and endocrine therapies on OET. CONCLUSIONS: The etiology and pathogenesis of ovarian cancer are still not fully understood. None of the so far proposed hypothesis on the development of OET can fully account for the epidemiologic and clinical findings in the context of reproductive factors and OET development. Further research approaches are warranted and need to put more weight on the clinical and genetical diversity of OET to yield a more detailed insight into their pathogenesis.
PURPOSE: The aim of this systematic review is to summarize the current knowledge about the etiology and pathogenesis of borderline tumors ovarian cancer with special emphasis on the role of endocrine treatments and reproductive factors to establish a foundation for future studies. METHODS: We performed a systematic review on the relation between ovarian epithelial tumors (OET) and reproductive factors using the keywords: ovarian cancer, ovarian tumor, ovarian borderline tumor, age at menarche, age at menopause, parity, infertility, PCO syndrome, oral contraception, menopausal hormone therapy, fertility treatment. Totally, 3,290 abstracts were scanned for their relevance in this publication and 127 were finally included. RESULTS: The incidence of ovarian epithelial cancer and ovarian borderline tumors is influenced by certain reproductive factors. The strongest protective effects are conferred by parity and use of oral contraceptive pills. Recent molecular biologic and histopathologic studies prove that OET represent a diverse group of tumors, each histologic type with a different genetic background. This is at least partly reflected in epidemiologic and clinical studies showing different risk modulating effects of reproductive factors and endocrine therapies on OET. CONCLUSIONS: The etiology and pathogenesis of ovarian cancer are still not fully understood. None of the so far proposed hypothesis on the development of OET can fully account for the epidemiologic and clinical findings in the context of reproductive factors and OET development. Further research approaches are warranted and need to put more weight on the clinical and genetical diversity of OET to yield a more detailed insight into their pathogenesis.
Authors: Melissa Z Braganza; Amy Berrington de González; Sara J Schonfeld; Nicolas Wentzensen; Alina V Brenner; Cari M Kitahara Journal: Cancer Prev Res (Phila) Date: 2014-01-21
Authors: Yi A Ren; Lisa K Mullany; Zhilin Liu; Alan J Herron; Kwong-Kwok Wong; JoAnne S Richards Journal: Cancer Res Date: 2016-03-10 Impact factor: 12.701
Authors: Christina B Rasmussen; Susanne K Kjaer; Vanna Albieri; Elisa V Bandera; Jennifer A Doherty; Estrid Høgdall; Penelope M Webb; Susan J Jordan; Mary Anne Rossing; Kristine G Wicklund; Marc T Goodman; Francesmary Modugno; Kirsten B Moysich; Roberta B Ness; Robert P Edwards; Joellen M Schildkraut; Andrew Berchuck; Sara H Olson; Lambertus A Kiemeney; Leon F A G Massuger; Steven A Narod; Catherine M Phelan; Hoda Anton-Culver; Argyrios Ziogas; Anna H Wu; Celeste L Pearce; Harvey A Risch; Allan Jensen Journal: Am J Epidemiol Date: 2016-12-09 Impact factor: 4.897
Authors: Patricia B Hoyer; Photini F Rice; Caitlin C Howard; Jennifer W Koevary; Joceline P Dominguez Cooks; Gabrielle V Hutchens; Setsuko K Chambers; Zelieann R Craig; Denise C Connolly; Jennifer K Barton Journal: Comp Med Date: 2018-12-27 Impact factor: 0.982
Authors: R Troisi; T Bjørge; M Gissler; T Grotmol; C M Kitahara; S M Myrtveit Saether; A G Ording; C Sköld; H T Sørensen; B Trabert; I Glimelius Journal: J Intern Med Date: 2018-03-25 Impact factor: 8.989
Authors: Renée T Fortner; Jennifer Ose; Melissa A Merritt; Helena Schock; Anne Tjønneland; Louise Hansen; Kim Overvad; Laure Dossus; Françoise Clavel-Chapelon; Laura Baglietto; Heiner Boeing; Antonia Trichopoulou; Vassiliki Benetou; Pagona Lagiou; Claudia Agnoli; Amalia Mattiello; Giovanna Masala; Rosario Tumino; Carlotta Sacerdote; H B As Bueno-de-Mesquita; N Charlotte Onland-Moret; Petra H Peeters; Elisabete Weiderpass; Inger Torhild Gram; Eric J Duell; Nerea Larrañaga; Eva Ardanaz; María-José Sánchez; M-D Chirlaque; Jenny Brändstedt; Annika Idahl; Eva Lundin; Kay-Tee Khaw; Nick Wareham; Ruth C Travis; Sabina Rinaldi; Isabelle Romieu; Marc J Gunter; Elio Riboli; Rudolf Kaaks Journal: Int J Cancer Date: 2015-02-26 Impact factor: 7.396